Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks: Sotio, EpimAb

February 27, 2018 10:33 PM UTC

Cancer and autoimmune disease company Sotio a.s. (Prague, Czech Republic) said CEO Ladislav Bartonícek will transition to the company's board, effective March 1. He is succeeded by CSO and Co-founder Radek Spíšek.

Bi-specific antibody company EpimAb Biotherapeutics Inc. (Shanghai, China) hired Bin Peng as CMO. He was global head of oncology translational medicine, China at Novartis AG (NYSE:NVS; SIX:NOVN)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article